These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31766496)

  • 1. Influence of the Sense of Coherence, the Doctor-Patient Relationship, Optimism and Non-Haematological Adverse Reactions on Health-Related Quality of Life in Patients with Breast Cancer.
    Prieto-Callejero B; Rivera F; Andrés-Villas M; Gómez-Salgado J
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Doctors' and Breast Cancer Patients' Perceptions of Docetaxel, Epirubicin, and Cyclophosphamide (TEC) Toxicity.
    Bayo J; Prieto B; Rivera F
    Breast J; 2016 May; 22(3):293-302. PubMed ID: 26864346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimism versus pessimism predicts the quality of women's adjustment to early stage breast cancer.
    Carver CS; Pozo-Kaderman C; Harris SD; Noriega V; Scheier MF; Robinson DS; Ketcham AS; Moffat FL; Clark KC
    Cancer; 1994 Feb; 73(4):1213-20. PubMed ID: 8313325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
    Cameron D; Morden JP; Canney P; Velikova G; Coleman R; Bartlett J; Agrawal R; Banerji J; Bertelli G; Bloomfield D; Brunt AM; Earl H; Ellis P; Gaunt C; Gillman A; Hearfield N; Laing R; Murray N; Couper N; Stein RC; Verrill M; Wardley A; Barrett-Lee P; Bliss JM;
    Lancet Oncol; 2017 Jul; 18(7):929-945. PubMed ID: 28600210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The sense of coherence and the quality of life of patients treated for breast cancer].
    Motyka M; Dziubak M; Patrycja J
    Przegl Lek; 2014; 71(5):270-3. PubMed ID: 25248242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer.
    Prieto-Callejero B; Rivera F; Fagundo-Rivera J; Romero A; Romero-Martín M; Gómez-Salgado J; Ruiz-Frutos C
    Medicine (Baltimore); 2020 Aug; 99(33):e21695. PubMed ID: 32872042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.
    Zaheed M; Wilcken N; Willson ML; O'Connell DL; Goodwin A
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012873. PubMed ID: 30776132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of high dose epirubicin in combination with cyclophosphamide in patients with advanced breast cancer.
    Levi JA; Beith JM; Snyder RD; Tattersall MH; Bell D; Wheeler H
    Aust N Z J Med; 1995 Oct; 25(5):474-8. PubMed ID: 8588767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antonovsky's Sense of Coherence in psychosomatic patients - a contribution to construct validation.
    Zirke N; Schmid G; Mazurek B; Klapp BF; Rauchfuss M
    Psychosoc Med; 2007 Apr; 4():Doc03. PubMed ID: 19742290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.
    Holmes FA; Hellerstedt BA; Pippen JE; Vukelja SJ; Collea RP; Kocs DM; Blum JL; McIntyre KJ; Barve MA; Brooks BD; Osborne CR; Wang Y; Asmar L; O'Shaughnessy J
    Cancer Med; 2018 Jun; 7(6):2288-2298. PubMed ID: 29582557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sense of coherence and its relationship to participation, cancer-related fatigue, symptom burden, and quality of life in women with breast cancer participating in the OptiTrain exercise trial.
    Hiensch AE; Bolam KA; Mijwel S; May AM; Wengström Y
    Support Care Cancer; 2020 Nov; 28(11):5371-5379. PubMed ID: 32140973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between knowledge of disease, depression and anxiety, social support, sense of coherence and optimism with health-related quality of life in an ambulatory sample of adolescents with heart disease.
    Wang Q; Hay M; Clarke D; Menahem S
    Cardiol Young; 2014 Feb; 24(1):126-33. PubMed ID: 23402427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life and sense of coherence among partners of women with breast cancer in Israel.
    Shor V; Grinstein-Cohen O; Reinshtein J; Liberman O; Delbar V
    Eur J Oncol Nurs; 2015 Feb; 19(1):18-22. PubMed ID: 25442372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of self-perceived limitations, stigma and sense of coherence on quality of life in multiple sclerosis patients: results of a cross-sectional study.
    Broersma F; Oeseburg B; Dijkstra J; Wynia K
    Clin Rehabil; 2018 Apr; 32(4):536-545. PubMed ID: 28895427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of sense of coherence to stressful events, coping strategies, health status, and quality of life in women with breast cancer.
    Kenne Sarenmalm E; Browall M; Persson LO; Fall-Dickson J; Gaston-Johansson F
    Psychooncology; 2013 Jan; 22(1):20-7. PubMed ID: 21910162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stigma and Quality of Life in Women With Breast Cancer: Mediation and Moderation Model of Social Support, Sense of Coherence, and Coping Strategies.
    Zamanian H; Amini-Tehrani M; Jalali Z; Daryaafzoon M; Ramezani F; Malek N; Adabimohazab M; Hozouri R; Rafiei Taghanaky F
    Front Psychol; 2022; 13():657992. PubMed ID: 35237203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sense of coherence as a mediator of health-related quality of life dimensions in patients with breast cancer: a longitudinal study with prospective design.
    Rohani C; Abedi HA; Sundberg K; Langius-Eklöf A
    Health Qual Life Outcomes; 2015 Dec; 13():195. PubMed ID: 26651334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.
    Au HJ; Eiermann W; Robert NJ; Pienkowski T; Crown J; Martin M; Pawlicki M; Chan A; Mackey J; Glaspy J; Pintér T; Liu MC; Fornander T; Sehdev S; Ferrero JM; Bée V; Santana MJ; Miller DP; Lalla D; Slamon DJ;
    Oncologist; 2013; 18(7):812-8. PubMed ID: 23814044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialist breast care nurses for support of women with breast cancer.
    Brown T; Cruickshank S; Noblet M
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD005634. PubMed ID: 34559420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.